Cite
MLA Citation
Majdoline Jayoushe et al.. “P040 Is Vedolizumab the Answer to Decreasing the Incidence of Immune-Mediated Colitis in Patients With Pre-Existing Inflammatory Bowel Disease?.” American journal of gastroenterology, vol. 114, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100122871287.0x00005c